Rainer Fuchs

Director/Miembro de la Junta en Egenix, Inc. .

Health Technology

Perfil

Dr. Rainer Fuchs is Chairman & President at Provasculon, Inc. He is on the Board of Directors at Egenix, Inc. Dr. Fuchs was previously employed as President by Escoublac, Inc.

Cargos activos de Rainer Fuchs

Empresas	Cargo	Inicio
Egenix, Inc. Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million.	Director/Miembro de la Junta	05/11/2012

Todos los cargos activos de Rainer Fuchs

Antiguos cargos conocidos de Rainer Fuchs.

Empresas	Cargo	Fin
Escoublac, Inc. Escoublac, Inc. BiotechnologyHealth Technology Escoublac, Inc. offers treatment for obesity and related disorders. It aims to transform the discovery into new therapies for metabolic disorders and related conditions such as obesity and type II diabetes. The company was founded in 2007 by Gerard Karsenty and is headquartered in Cambridge, MA.	Presidente	-
Provasculon, Inc. Provasculon, Inc. Pharmaceuticals: MajorHealth Technology Provasculon, Inc. developed new treatments for chronic wounds and cardiovascular diseases. The company was founded by Thomas Lee Richard and Vincent M. Segers in 2008 and was headquartered in Boston, MA.	Presidente	-

Ver el detalle de la experiencia de Rainer Fuchs.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Rainer Fuchs.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	3
Provasculon, Inc. Provasculon, Inc. Pharmaceuticals: MajorHealth Technology Provasculon, Inc. developed new treatments for chronic wounds and cardiovascular diseases. The company was founded by Thomas Lee Richard and Vincent M. Segers in 2008 and was headquartered in Boston, MA.	Health Technology
Escoublac, Inc. Escoublac, Inc. BiotechnologyHealth Technology Escoublac, Inc. offers treatment for obesity and related disorders. It aims to transform the discovery into new therapies for metabolic disorders and related conditions such as obesity and type II diabetes. The company was founded in 2007 by Gerard Karsenty and is headquartered in Cambridge, MA.	Health Technology
Egenix, Inc. Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million.	Health Technology

Ver las conexiones de la empresa